Proof of Usefulness Report

IncellDx

Analysis completed on 3/24/2026

+92.25

Proof of Usefulness Score

You're In Business

The submission for IncellDx via HealthBioAI presents a potentially valid biotechnology focus (AI/ML in precision diagnostics) but is severely undermined by highly exaggerated, unverifiable claims ('most people have used my product', 'everyone' as audience). The extreme disconnect between a claimed 125-person team, a 2009 launch, and a bizarrely stated $2.5M market cap, combined with alias usage ('CrimsonRider'), heavily penalizes the response quality and traction scores. The overall lack of credible, substantive evidence leads to a low Proof of Usefulness score.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+50

Audience Reach Impact+5

Technical Innovation+22.5

Evidence Of Traction+0

Market Timing Relevance+40

Functional Completeness-5

Subtotal+112.5

Usefulness Multiplierx0.82

Final Score+92

Project Details

Project URL

healthbioai.com

Description

HealthBioAI, has identified a common thread in chronic inflammatory diseases through the use of machine learning and AI-based precision diagnostics.

Algorithm Insights

Market Position

Growing utility with room for optimization

User Engagement

Documented reach suggests active user community

Technical Stack

Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline